These lab-built choices were not formulated with leisure use in mind. In the nineteen nineties, John W. Huffman along with a staff of fellow chemists at Clemson University produced some of the first formulation for synthetic cannabinoid receptor agonists (SCRAs), a family of substances that imitate the physiological and psychological impacts of can